Table 3. Nephridial levels of TNF-α (pg mg–1 protein), IL-1β (pg mg–1 protein) and IL-6 (pg mg–1 protein) and nephridial iNOS (U mg–1 protein) activities.
| Groups | TNF-α (pg mL–1) | IL-1β (pg mL–1) | IL-6 (pg mL–1) | iNOS (U mg–1) |
| Normal control | 59.74 ± 1.18 b | 12.35 ± 0.13 b | 8.44 ± 0.32 b | 0.48 ± 0.10 b |
| Model control | 250.15 ± 8.10 | 18.34 ± 0.25 | 20.85 ± 0.11 | 1.98 ± 0.12 |
| Positive control (HC) | 105.32 ± 8.32 b | 14.81 ± 0.37 b | 12.28 ± 0.42 b | 0.81 ± 0.02 b |
| Low dose LIM | 218.12 ± 7.22 a | 17.66 ± 0.24 a | 18.27 ± 0.72 a | 1.79 ± 0.26 a |
| High dose LIM | 168.32 ± 6.54 b | 16.03 ± 0.17 a | 14.16 ± 0.09 b | 1.64 ± 0.26 a |
| Low dose LIM + HC | 98.13 ± 6.78 b | 14.51 ± 0.34 b | 12.07 ± 0.07 b | 0.79 ± 0.34 b |
| High dose LIM + HC | 84.35 ± 5.70 b | 13.81 ± 0.24 b | 10.74 ± 0.03 b | 0.68 ± 0.27 b |
a p < 0.05, significantly different from model control group.
b p < 0.01, highly significantly different from model control group. The mice in each group were ten.